Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Primary tabs

Crosignani, Stefano Bingham, Patrick Bottemanne, Pauline Cannelle, Hélène Cauwenberghs, Sandra Van den Eynde, Benoît [UCL]

Wythes, Martin et al.[show all]

Document type	Article de périodique (Journal article) – Article de recherche
Access type	Accès restreint
Publication date	2017
Language	Anglais
Journal information	"Journal of Medicinal Chemistry" - Vol. 60, p. 9617-9629 (2017)
Peer reviewed	yes
Publisher	American Chemical Society (ACS)
issn	0022-2623
e-issn	1520-4804
Publication status	Publié
Affiliation	UCL - SSS/DDUV - Institut de Duve
Keywords	Molecular Medicine ; Drug Discovery
Links	https://doi.org/10.1021/acs.jmedchem.7b00974[DOI] http://hdl.handle.net/2078.1/194331[Handle] https://www.ncbi.nlm.nih.gov/pubmed/29111717[Pubmed]

Bibliographic reference	Crosignani, Stefano ; Bingham, Patrick ; Bottemanne, Pauline ; Cannelle, Hélène ; Cauwenberghs, Sandra ; et. al. Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate. In: Journal of Medicinal Chemistry, Vol. 60, p. 9617-9629 (2017)
Permanent URL	http://hdl.handle.net/2078.1/194331